The Week In Psychedelics
- Seattle Decriminalizes Psychedelics Along With California City
- Novamind Launches Program For End-Of-Life And Palliative Care Patients
- MindMed Teams Up With Sphere Health
- Former Tilray CEO Joins Psychedelics Company
- House Representative Promises A Psychedelics Bill Before 2022
- Study: Psilocybin Increases Emotional Response To Music
- The Milestone Round
Seattle Decriminalizes Psychedelics Along With California City
Last Monday, Seattle became the largest U.S. city to decriminalize psychedelic substances, with the passage of Resolution 32021. The measure, approved unanimously, concluded that “the investigation, arrest, and prosecution of anyone engaging in entheogen-related activities should be among Seattle’s lowest law enforcement priorities.”
This measure follows current enforcement rules of the Seattle Police Department that disallow the detention or arrest of individuals or confiscation of drugs simply on suspicion of possessing psychedelics. The new rules aim to protect “individuals who cultivate entheogens for use in religious, spiritual, healing, or personal growth practices.”
Councilmember Andrew J. Lewis, who introduced the measure, thanked his colleagues who voted for the measure.
“It is a long-overdue conversation to decriminalize these non-addictive natural substances,” Lewis said. “Our law enforcement officials certainly have more important things to do than arrest people for possession of entheogens, and this resolution affirms that.”
Days after Seattle, the city of Arcata in California passed a similar measure.
The City Council of Arcata unanimously voted on a resolution “To Decriminalize Entheogens in Arcata.”
“The investigation and arrest of individuals twenty-one years of age and older involved with the adult personal use, cultivation and possession of entheogenic plants and fungi listed on the Federal Schedule 1 list, not be a priority for the City of Arcata,” agreed the council.
Novamind Launches Program For End-Of-Life And Palliative Care Patients
Novamind (Canadian:NM) (OTCQB: NVMDF) announced a new program for palliative care patients experiencing chronic and serious illnesses.
The program will take place at Novamind’s recently-opened clinic and research site in Murray, Utah where it will welcome family members of the patients.
Initially, the program will combine ketamine treatment with psychotherapy, workshops, multi-day immersive …